Home
About
Overview
Sharing Data
ORCID
Help
History (169)
Revised NESARC personality disorder diagnoses: gender, prevalence, and comorbidity with substance dependence disorders.
Using increased trust in medical researchers to increase minority recruitment: The RECRUIT cluster randomized clinical trial.
Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders.
Organogenesis and development of the liver.
Autophagy Inhibition Enables Nrf2 to Exaggerate the Progression of Diabetic Cardiomyopathy in Mice.
See All 169 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Autophagy Inhibition Enables Nrf2 to Exaggerate the Progression of Diabetic Cardiomyopathy in Mice.
Autophagy Inhibition Enables Nrf2 to Exaggerate the Progression of Diabetic Cardiomyopathy in Mice. Diabetes. 2020 12; 69(12):2720-2734.
View in:
PubMed
subject areas
Animals
Autophagy
Cell Line
Diabetic Cardiomyopathies
Mice
Mice, Knockout
Myoblasts
NF-E2-Related Factor 2
Rats
authors with profiles
Taixing Cui
Mitzi Nagarkatti
Wenbin Tan